BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu J, Liao M, Yao Z, Liang W, Li Q, Liu J, Yang H, Ji Y, Wei W, Tan A, Liang S, Chen Y, Lin H, Zhu X, Huang S, Tian J, Tang R, Wang Q, Mo Z. Breast cancer in postmenopausal women is associated with an altered gut metagenome. Microbiome 2018;6:136. [PMID: 30081953 DOI: 10.1186/s40168-018-0515-3] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 14.5] [Reference Citation Analysis]
Number Citing Articles
1 Hou MF, Ou-Yang F, Li CL, Chen FM, Chuang CH, Kan JY, Wu CC, Shih SL, Shiau JP, Kao LC, Kao CN, Lee YC, Moi SH, Yeh YT, Cheng CJ, Chiang CP. Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancer. Exp Mol Med 2021;53:1636-46. [PMID: 34707191 DOI: 10.1038/s12276-021-00686-9] [Reference Citation Analysis]
2 Gao G, Ma T, Zhang T, Jin H, Li Y, Kwok LY, Zhang H, Sun Z. Adjunctive Probiotic Lactobacillus rhamnosus Probio-M9 Administration Enhances the Effect of Anti-PD-1 Antitumor Therapy via Restoring Antibiotic-Disrupted Gut Microbiota. Front Immunol 2021;12:772532. [PMID: 34970262 DOI: 10.3389/fimmu.2021.772532] [Reference Citation Analysis]
3 Li Y, Dong B, Wu W, Wang J, Jin H, Chen K, Huang K, Huang S, Yao Y. Metagenomic Analyses Reveal Distinct Gut Microbiota Signature for Predicting the Neoadjuvant Chemotherapy Responsiveness in Breast Cancer Patients. Front Oncol 2022;12:865121. [DOI: 10.3389/fonc.2022.865121] [Reference Citation Analysis]
4 Armstrong H, Bording-Jorgensen M, Wine E. The Multifaceted Roles of Diet, Microbes, and Metabolites in Cancer. Cancers (Basel) 2021;13:767. [PMID: 33673140 DOI: 10.3390/cancers13040767] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lasagna A, Zuccaro V, Ferraris E, Corbella M, Bruno R, Pedrazzoli P. COVID-19 and breast cancer: may the microbiome be the issue? Future Oncol 2021;17:123-6. [PMID: 33244989 DOI: 10.2217/fon-2020-0764] [Reference Citation Analysis]
6 Picardo SL, Coburn B, Hansen AR. The microbiome and cancer for clinicians. Crit Rev Oncol Hematol. 2019;141:1-12. [PMID: 31202124 DOI: 10.1016/j.critrevonc.2019.06.004] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 11.0] [Reference Citation Analysis]
7 Huybrechts I, Zouiouich S, Loobuyck A, Vandenbulcke Z, Vogtmann E, Pisanu S, Iguacel I, Scalbert A, Indave I, Smelov V, Gunter MJ, Michels N. The Human Microbiome in Relation to Cancer Risk: A Systematic Review of Epidemiologic Studies. Cancer Epidemiol Biomarkers Prev 2020;29:1856-68. [PMID: 32727720 DOI: 10.1158/1055-9965.EPI-20-0288] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
8 Lee MH. Harness the functions of gut microbiome in tumorigenesis for cancer treatment. Cancer Commun (Lond) 2021. [PMID: 34355542 DOI: 10.1002/cac2.12200] [Reference Citation Analysis]
9 Schreurs MPH, de Vos van Steenwijk PJ, Romano A, Dieleman S, Werner HMJ. How the Gut Microbiome Links to Menopause and Obesity, with Possible Implications for Endometrial Cancer Development. J Clin Med 2021;10:2916. [PMID: 34209916 DOI: 10.3390/jcm10132916] [Reference Citation Analysis]
10 Andrade FO, Liu F, Zhang X, Rosim MP, Dani C, Cruz I, Wang TTY, Helferich W, Li RW, Hilakivi-Clarke L. Genistein Reduces the Risk of Local Mammary Cancer Recurrence and Ameliorates Alterations in the Gut Microbiota in the Offspring of Obese Dams. Nutrients 2021;13:201. [PMID: 33440675 DOI: 10.3390/nu13010201] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Laborda-Illanes A, Sanchez-Alcoholado L, Dominguez-Recio ME, Jimenez-Rodriguez B, Lavado R, Comino-Méndez I, Alba E, Queipo-Ortuño MI. Breast and Gut Microbiota Action Mechanisms in Breast Cancer Pathogenesis and Treatment. Cancers (Basel) 2020;12:E2465. [PMID: 32878124 DOI: 10.3390/cancers12092465] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
12 Sampsell K, Hao D, Reimer RA. The Gut Microbiota: A Potential Gateway to Improved Health Outcomes in Breast Cancer Treatment and Survivorship. Int J Mol Sci 2020;21:E9239. [PMID: 33287442 DOI: 10.3390/ijms21239239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Mikó E, Kovács T, Sebő É, Tóth J, Csonka T, Ujlaki G, Sipos A, Szabó J, Méhes G, Bai P. Microbiome-Microbial Metabolome-Cancer Cell Interactions in Breast Cancer-Familiar, but Unexplored. Cells 2019;8:E293. [PMID: 30934972 DOI: 10.3390/cells8040293] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 15.3] [Reference Citation Analysis]
14 Groot HE, van de Vegte YJ, Verweij N, Lipsic E, Karper JC, van der Harst P. Human genetic determinants of the gut microbiome and their associations with health and disease: a phenome-wide association study. Sci Rep 2020;10:14771. [PMID: 32901066 DOI: 10.1038/s41598-020-70724-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
15 Parida S, Sharma D. The Microbiome-Estrogen Connection and Breast Cancer Risk. Cells 2019;8:E1642. [PMID: 31847455 DOI: 10.3390/cells8121642] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 8.3] [Reference Citation Analysis]
16 Aarnoutse R, Hillege LE, Ziemons J, De Vos-Geelen J, de Boer M, Aerts EMER, Vriens BEPJ, van Riet Y, Vincent J, van de Wouw AJ, Le GN, Venema K, Rensen SS, Penders J, Smidt ML. Intestinal Microbiota in Postmenopausal Breast Cancer Patients and Controls. Cancers (Basel) 2021;13:6200. [PMID: 34944820 DOI: 10.3390/cancers13246200] [Reference Citation Analysis]
17 Kartal E, Schmidt TSB, Molina-Montes E, Rodríguez-Perales S, Wirbel J, Maistrenko OM, Akanni WA, Alashkar Alhamwe B, Alves RJ, Carrato A, Erasmus HP, Estudillo L, Finkelmeier F, Fullam A, Glazek AM, Gómez-Rubio P, Hercog R, Jung F, Kandels S, Kersting S, Langheinrich M, Márquez M, Molero X, Orakov A, Van Rossum T, Torres-Ruiz R, Telzerow A, Zych K, Benes V, Zeller G, Trebicka J, Real FX, Malats N, Bork P; MAGIC Study investigators., PanGenEU Study investigators. A faecal microbiota signature with high specificity for pancreatic cancer. Gut 2022:gutjnl-2021-324755. [PMID: 35260444 DOI: 10.1136/gutjnl-2021-324755] [Reference Citation Analysis]
18 Zhang J, Zhang F, Zhao C, Xu Q, Liang C, Yang Y, Wang H, Shang Y, Wang Y, Mu X, Zhu D, Zhang C, Yang J, Yao M, Zhang L. Dysbiosis of the gut microbiome is associated with thyroid cancer and thyroid nodules and correlated with clinical index of thyroid function. Endocrine 2019;64:564-74. [PMID: 30584647 DOI: 10.1007/s12020-018-1831-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
19 Bobin-Dubigeon C, Bard JM, Luu TH, Le Vacon F, Nazih H. Basolateral Secretion from Caco-2 Cells Pretreated with Fecal Waters from Breast Cancer Patients Affects MCF7 Cell Viability. Nutrients 2020;13:E31. [PMID: 33374116 DOI: 10.3390/nu13010031] [Reference Citation Analysis]
20 Romano-Keeler J, Zhang J, Sun J. The Life-Long Role of Nutrition on the Gut Microbiome and Gastrointestinal Disease. Gastroenterol Clin North Am 2021;50:77-100. [PMID: 33518170 DOI: 10.1016/j.gtc.2020.10.008] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Ruo SW, Alkayyali T, Win M, Tara A, Joseph C, Kannan A, Srivastava K, Ochuba O, Sandhu JK, Went TR, Sultan W, Kantamaneni K, Poudel S. Role of Gut Microbiota Dysbiosis in Breast Cancer and Novel Approaches in Prevention, Diagnosis, and Treatment. Cureus 2021;13:e17472. [PMID: 34513524 DOI: 10.7759/cureus.17472] [Reference Citation Analysis]
22 Mansour SR, Moustafa MAA, Saad BM, Hamed R, Moustafa AA. Impact of diet on human gut microbiome and disease risk. New Microbes New Infect 2021;41:100845. [PMID: 34035924 DOI: 10.1016/j.nmni.2021.100845] [Reference Citation Analysis]
23 Liu B, Lin W, Chen S, Xiang T, Yang Y, Yin Y, Xu G, Liu Z, Liu L, Pan J, Xie L. Gut Microbiota as an Objective Measurement for Auxiliary Diagnosis of Insomnia Disorder. Front Microbiol 2019;10:1770. [PMID: 31456757 DOI: 10.3389/fmicb.2019.01770] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 8.3] [Reference Citation Analysis]
24 Aguilera M, Gálvez-Ontiveros Y, Rivas A. Endobolome, a New Concept for Determining the Influence of Microbiota Disrupting Chemicals (MDC) in Relation to Specific Endocrine Pathogenesis. Front Microbiol 2020;11:578007. [PMID: 33329442 DOI: 10.3389/fmicb.2020.578007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
25 Singh RP, Bashir H, Kumar R. Emerging role of microbiota in immunomodulation and cancer immunotherapy. Semin Cancer Biol 2021;70:37-52. [PMID: 32580024 DOI: 10.1016/j.semcancer.2020.06.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Jia B, Park D, Hahn Y, Jeon CO. Metagenomic analysis of the human microbiome reveals the association between the abundance of gut bile salt hydrolases and host health. Gut Microbes 2020;11:1300-13. [PMID: 32329665 DOI: 10.1080/19490976.2020.1748261] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
27 Ibragimova S, Ramachandran R, Ali FR, Lipovich L, Ho SB. Dietary Patterns and Associated Microbiome Changes that Promote Oncogenesis. Front Cell Dev Biol 2021;9:725821. [PMID: 34869313 DOI: 10.3389/fcell.2021.725821] [Reference Citation Analysis]
28 Mao X, Peng X, Pan Q, Zhao X, Yu Z, Xu D. Uterine Fibroid Patients Reveal Alterations in the Gut Microbiome. Front Cell Infect Microbiol 2022;12:863594. [DOI: 10.3389/fcimb.2022.863594] [Reference Citation Analysis]
29 Terrisse S, Derosa L, Iebba V, Ghiringhelli F, Vaz-Luis I, Kroemer G, Fidelle M, Christodoulidis S, Segata N, Thomas AM, Martin AL, Sirven A, Everhard S, Aprahamian F, Nirmalathasan N, Aarnoutse R, Smidt M, Ziemons J, Caldas C, Loibl S, Denkert C, Durand S, Iglesias C, Pietrantonio F, Routy B, André F, Pasolli E, Delaloge S, Zitvogel L. Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment. Cell Death Differ 2021. [PMID: 33963313 DOI: 10.1038/s41418-021-00784-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
30 Al-Ansari MM, AlMalki RH, Dahabiyeh LA, Abdel Rahman AM. Metabolomics-Microbiome Crosstalk in the Breast Cancer Microenvironment. Metabolites 2021;11:758. [PMID: 34822416 DOI: 10.3390/metabo11110758] [Reference Citation Analysis]
31 Kovács T, Mikó E, Ujlaki G, Yousef H, Csontos V, Uray K, Bai P. The involvement of oncobiosis and bacterial metabolite signaling in metastasis formation in breast cancer. Cancer Metastasis Rev 2021. [PMID: 34967927 DOI: 10.1007/s10555-021-10013-3] [Reference Citation Analysis]
32 Ukrainets RV, Korneva YS, Dorosevich AE. [Abnormal gut microbiota-induced hypoestrogenemia as a possible risk factor for malignancy in endometrioid heterotopia]. Arkh Patol 2020;82:57-61. [PMID: 32307440 DOI: 10.17116/patol20208202157] [Reference Citation Analysis]
33 Teng NMY, Price CA, McKee AM, Hall LJ, Robinson SD. Exploring the impact of gut microbiota and diet on breast cancer risk and progression. Int J Cancer 2021;149:494-504. [PMID: 33521932 DOI: 10.1002/ijc.33496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
34 Kim JR, Han K, Han Y, Kang N, Shin TS, Park HJ, Kim H, Kwon W, Lee S, Kim YK, Park T, Jang JY. Microbiome Markers of Pancreatic Cancer Based on Bacteria-Derived Extracellular Vesicles Acquired from Blood Samples: A Retrospective Propensity Score Matching Analysis. Biology (Basel) 2021;10:219. [PMID: 33805810 DOI: 10.3390/biology10030219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Zhang Z, Tang H, Chen P, Xie H, Tao Y. Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome. Signal Transduct Target Ther 2019;4:41. [PMID: 31637019 DOI: 10.1038/s41392-019-0074-5] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 17.7] [Reference Citation Analysis]
36 Alpuim Costa D, Nobre JG, Batista MV, Ribeiro C, Calle C, Cortes A, Marhold M, Negreiros I, Borralho P, Brito M, Cortes J, Braga SA, Costa L. Human Microbiota and Breast Cancer-Is There Any Relevant Link?-A Literature Review and New Horizons Toward Personalised Medicine. Front Microbiol 2021;12:584332. [PMID: 33716996 DOI: 10.3389/fmicb.2021.584332] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
37 Liu HM, Lin X, Meng XH, Zhao Q, Shen J, Xiao HM, Deng HW. Integrated metagenome and metabolome analyses of blood pressure studies in early postmenopausal Chinese women. J Hypertens 2021;39:1800-9. [PMID: 33758158 DOI: 10.1097/HJH.0000000000002832] [Reference Citation Analysis]
38 Sári Z, Mikó E, Kovács T, Boratkó A, Ujlaki G, Jankó L, Kiss B, Uray K, Bai P. Indoxylsulfate, a Metabolite of the Microbiome, Has Cytostatic Effects in Breast Cancer via Activation of AHR and PXR Receptors and Induction of Oxidative Stress. Cancers (Basel) 2020;12:E2915. [PMID: 33050543 DOI: 10.3390/cancers12102915] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
39 Sui Y, Wu J, Chen J. The Role of Gut Microbial β-Glucuronidase in Estrogen Reactivation and Breast Cancer. Front Cell Dev Biol 2021;9:631552. [PMID: 34458248 DOI: 10.3389/fcell.2021.631552] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Pothmann A, Illing T, Wiegand C, Hartmann AA, Elsner P. The Microbiome and Atopic Dermatitis: A Review. Am J Clin Dermatol 2019;20:749-61. [PMID: 31444782 DOI: 10.1007/s40257-019-00467-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
41 Khangwal I, Shukla P. Combinatory biotechnological intervention for gut microbiota. Appl Microbiol Biotechnol 2019;103:3615-25. [DOI: 10.1007/s00253-019-09727-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
42 Sári Z, Mikó E, Kovács T, Jankó L, Csonka T, Lente G, Sebő É, Tóth J, Tóth D, Árkosy P, Boratkó A, Ujlaki G, Török M, Kovács I, Szabó J, Kiss B, Méhes G, Goedert JJ, Bai P. Indolepropionic Acid, a Metabolite of the Microbiome, Has Cytostatic Properties in Breast Cancer by Activating AHR and PXR Receptors and Inducing Oxidative Stress. Cancers (Basel) 2020;12:E2411. [PMID: 32854297 DOI: 10.3390/cancers12092411] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
43 Yang P, Wang Z, Peng Q, Lian W, Chen D. Comparison of the Gut Microbiota in Patients with Benign and Malignant Breast Tumors: A Pilot Study. Evol Bioinform Online 2021;17:11769343211057573. [PMID: 34795472 DOI: 10.1177/11769343211057573] [Reference Citation Analysis]
44 Hang Z, Lei T, Zeng Z, Cai S, Bi W, Du H. Composition of intestinal flora affects the risk relationship between Alzheimer's disease/Parkinson's disease and cancer. Biomed Pharmacother 2022;145:112343. [PMID: 34864312 DOI: 10.1016/j.biopha.2021.112343] [Reference Citation Analysis]
45 Vergara D, Simeone P, Damato M, Maffia M, Lanuti P, Trerotola M. The Cancer Microbiota: EMT and Inflammation as Shared Molecular Mechanisms Associated with Plasticity and Progression. J Oncol 2019;2019:1253727. [PMID: 31772577 DOI: 10.1155/2019/1253727] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 7.7] [Reference Citation Analysis]
46 Sharma M, Arora I, Stoll ML, Li Y, Morrow CD, Barnes S, Berryhill TF, Li S, Tollefsbol TO. Nutritional combinatorial impact on the gut microbiota and plasma short-chain fatty acids levels in the prevention of mammary cancer in Her2/neu estrogen receptor-negative transgenic mice. PLoS One 2020;15:e0234893. [PMID: 33382695 DOI: 10.1371/journal.pone.0234893] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
47 Han B, Jiang P, Jiang L, Li X, Ye X. Three phytosterols from sweet potato inhibit MCF7-xenograft-tumor growth through modulating gut microbiota homeostasis and SCFAs secretion. Food Res Int 2021;141:110147. [PMID: 33642013 DOI: 10.1016/j.foodres.2021.110147] [Reference Citation Analysis]
48 Jarman R, Ribeiro-Milograna S, Kalle W. Potential of the Microbiome as a Biomarker for Early Diagnosis and Prognosis of Breast Cancer. J Breast Cancer 2020;23:579-87. [PMID: 33408884 DOI: 10.4048/jbc.2020.23.e60] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Byrd DA, Vogtmann E, Wu Z, Han Y, Wan Y, Clegg-Lamptey JN, Yarney J, Wiafe-Addai B, Wiafe S, Awuah B, Ansong D, Nyarko K, Hullings AG, Hua X, Ahearn T, Goedert JJ, Shi J, Knight R, Figueroa JD, Brinton LA, Garcia-Closas M, Sinha R. Associations of fecal microbial profiles with breast cancer and nonmalignant breast disease in the Ghana Breast Health Study. Int J Cancer 2021;148:2712-23. [PMID: 33460452 DOI: 10.1002/ijc.33473] [Reference Citation Analysis]
50 Ryu G, Kim H, Koh A. Approaching precision medicine by tailoring the microbiota. Mamm Genome 2021;32:206-22. [PMID: 33646347 DOI: 10.1007/s00335-021-09859-3] [Reference Citation Analysis]
51 Su J, Chen X, Xiao Y, Li D, Li M, Li H, Huang J, Lai Z, Su Z, Xie Y, Zhu D, Chen Q, Lu H, He J, Xia C. Bruceae Fructus Oil Inhibits Triple-Negative Breast Cancer by Restraining Autophagy: Dependence on the Gut Microbiota-Mediated Amino Acid Regulation. Front Pharmacol 2021;12:727082. [PMID: 34658867 DOI: 10.3389/fphar.2021.727082] [Reference Citation Analysis]
52 Guan X, Ma F, Sun X, Li C, Li L, Liang F, Li S, Yi Z, Liu B, Xu B. Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage. Front Oncol 2020;10:902. [PMID: 32733788 DOI: 10.3389/fonc.2020.00902] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
53 McKee AM, Kirkup BM, Madgwick M, Fowler WJ, Price CA, Dreger SA, Ansorge R, Makin KA, Caim S, Le Gall G, Paveley J, Leclaire C, Dalby M, Alcon-Giner C, Andrusaite A, Feng TY, Di Modica M, Triulzi T, Tagliabue E, Milling SWF, Weilbaecher KN, Rutkowski MR, Korcsmáros T, Hall LJ, Robinson SD. Antibiotic-induced disturbances of the gut microbiota result in accelerated breast tumor growth. iScience 2021;24:103012. [PMID: 34522855 DOI: 10.1016/j.isci.2021.103012] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
54 Haque S, Raina R, Afroze N, Hussain A, Alsulimani A, Singh V, Mishra BN, Kaul S, Kharwar RN. Microbial dysbiosis and epigenetics modulation in cancer development - A chemopreventive approach. Semin Cancer Biol 2021:S1044-579X(21)00194-2. [PMID: 34216789 DOI: 10.1016/j.semcancer.2021.06.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
55 Tian W, Yang L, Wu D, Deng Z, Hong K. Toxicity, Pharmacokinetics, and Gut Microbiome of Oral Administration of Sesterterpene MHO7 Derived from a Marine Fungus. Mar Drugs 2019;17:E667. [PMID: 31779201 DOI: 10.3390/md17120667] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
56 Luo J, Yu J, Peng X. Could partial nonstarch polysaccharides ameliorate cancer by altering m6A RNA methylation in hosts through intestinal microbiota? Crit Rev Food Sci Nutr 2021;:1-16. [PMID: 34036843 DOI: 10.1080/10408398.2021.1927975] [Reference Citation Analysis]
57 Zhao H, Chen J, Li X, Sun Q, Qin P, Wang Q. Compositional and functional features of the female premenopausal and postmenopausal gut microbiota. FEBS Lett 2019;593:2655-64. [PMID: 31273779 DOI: 10.1002/1873-3468.13527] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
58 Liu B, Pan X, Liu Z, Han M, Xu G, Dai X, Wang W, Zhang H, Xie L. Fecal microbiota as a noninvasive biomarker to predict the tissue iron accumulation in intestine epithelial cells and liver. FASEB J 2020;34:3006-20. [PMID: 31912587 DOI: 10.1096/fj.201901635RR] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
59 He C, Liu Y, Ye S, Yin S, Gu J. Changes of intestinal microflora of breast cancer in premenopausal women. Eur J Clin Microbiol Infect Dis 2021;40:503-13. [PMID: 32936397 DOI: 10.1007/s10096-020-04036-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
60 Aarnoutse R, Ziemons J, Penders J, Rensen SS, de Vos-Geelen J, Smidt ML. The Clinical Link between Human Intestinal Microbiota and Systemic Cancer Therapy. Int J Mol Sci 2019;20:E4145. [PMID: 31450659 DOI: 10.3390/ijms20174145] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
61 Meng Z, Ye Z, Zhu P, Zhu J, Fang S, Qiu T, Li Y, Meng L. New Developments and Opportunities of Microbiota in Treating Breast Cancers. Front Microbiol 2022;13:818793. [DOI: 10.3389/fmicb.2022.818793] [Reference Citation Analysis]
62 Veziant J, Villéger R, Barnich N, Bonnet M. Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer. Cancers (Basel) 2021;13:2215. [PMID: 34063108 DOI: 10.3390/cancers13092215] [Reference Citation Analysis]
63 Olvera-Rosales LB, Cruz-Guerrero AE, Ramírez-Moreno E, Quintero-Lira A, Contreras-López E, Jaimez-Ordaz J, Castañeda-Ovando A, Añorve-Morga J, Calderón-Ramos ZG, Arias-Rico J, González-Olivares LG. Impact of the Gut Microbiota Balance on the Health-Disease Relationship: The Importance of Consuming Probiotics and Prebiotics. Foods 2021;10:1261. [PMID: 34199351 DOI: 10.3390/foods10061261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
64 Rao Malla R, Marni R, Kumari S, Chakraborty A, Lalitha P. Microbiome Assisted Tumor Microenvironment: Emerging Target of Breast Cancer. Clin Breast Cancer 2021:S1526-8209(21)00260-3. [PMID: 34625387 DOI: 10.1016/j.clbc.2021.09.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 Jaye K, Li CG, Bhuyan DJ. The complex interplay of gut microbiota with the five most common cancer types: From carcinogenesis to therapeutics to prognoses. Crit Rev Oncol Hematol 2021;165:103429. [PMID: 34293459 DOI: 10.1016/j.critrevonc.2021.103429] [Reference Citation Analysis]
66 Zhang J, Xia Y, Sun J. Breast and gut microbiome in health and cancer. Genes Dis 2021;8:581-9. [PMID: 34291130 DOI: 10.1016/j.gendis.2020.08.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Sui S, Xu S, Pang D. Emerging role of ferroptosis in breast cancer: New dawn for overcoming tumor progression. Pharmacol Ther 2021;:107992. [PMID: 34606782 DOI: 10.1016/j.pharmthera.2021.107992] [Reference Citation Analysis]